Gold of Pleasure Seed Oil (Camelina sativa)

Camelina sativa oil contains high levels of alpha-linolenic acid (ALA), an omega-3 fatty acid that comprises 35-40% of its composition. The ALA converts to EPA and DHA in the body, supporting cardiovascular health and reducing inflammation through prostaglandin and leukotriene pathways.

Origin & History

Gold of Pleasure Seed Oil is derived from the seeds of Camelina sativa, an annual oilseed plant in the Brassicaceae family native to Europe and Central Asia. The oil is extracted via cold-pressing or solvent methods from the seeds, yielding a lipid-rich product high in omega-3 alpha-linolenic acid (ALA) and antioxidants.

Historical & Cultural Context

No evidence of traditional medicinal use was identified in the research. Camelina sativa is primarily noted as a modern oilseed crop for nutrition and biotechnology applications, not in traditional herbal medicine contexts.

Health Benefits

• Improves lipid profile and reduces cardiovascular disease risk markers in NAFLD patients (Strong evidence - Meta-analysis PMID: 36476379)
• Reduces liver enzymes (ALT) and increases beneficial adiponectin in fatty liver disease (Moderate evidence - RCT n=46, PMID: 35421019)
• Enhances glycemic control and reduces inflammation markers (Moderate evidence - RCT PMID: 34423525)
• Significantly elevates serum omega-3 ALA levels within 12 weeks (Strong evidence - RCT n=66, p<0.01, PMID: 37357331)
• Supports metabolic health when combined with weight-loss interventions (Moderate evidence - Multiple RCTs in NAFLD patients)

How It Works

Alpha-linolenic acid in camelina oil undergoes desaturation and elongation via delta-6 and delta-5 desaturase enzymes to produce EPA and DHA. These omega-3 metabolites modulate prostaglandin E3 and leukotriene B5 synthesis, reducing inflammatory cytokines like TNF-α and IL-6. The oil also activates PPAR-α receptors, enhancing fatty acid oxidation and improving lipid metabolism.

Scientific Research

Clinical evidence includes several RCTs in NAFLD patients (n=44-46) and older adults (n=66), with 12-week interventions using 20-35g/day of camelina oil showing improvements in lipid profiles, liver enzymes, and metabolic markers (PMIDs: 35421019, 37357331, 34338703, 34423525). A meta-analysis of RCTs confirmed improvements in lipid profile and glycemic control (PMID: 36476379).

Clinical Summary

A meta-analysis (PMID: 36476379) demonstrated strong evidence for camelina oil's ability to improve lipid profiles and reduce cardiovascular risk markers in NAFLD patients. A randomized controlled trial with 46 participants (PMID: 35421019) showed moderate evidence for reducing ALT liver enzymes by 23% and increasing adiponectin levels by 15% over 12 weeks. Additional studies suggest improved glycemic control, though more research is needed to establish optimal dosing protocols.

Nutritional Profile

Camelina sativa seed oil is characterized by an exceptional fatty acid composition: alpha-linolenic acid (ALA, omega-3): 28-40% of total fatty acids (one of the richest plant-based omega-3 sources); linoleic acid (omega-6): 15-20%; oleic acid (omega-9): 14-20%; eicosenoic acid (omega-9, C20:1): 10-15%; erucic acid: 2-5% (low, within safe limits). Omega-6:omega-3 ratio approximately 1:2 to 1:3, which is nutritionally favorable and rare among plant oils. Saturated fat content is low at 9-11% (primarily palmitic and stearic acids). Rich in tocols (vitamin E complex) at 700-900 mg/kg total, predominantly gamma-tocopherol (50-60% of tocol fraction) and delta-tocopherol, contributing to oxidative stability despite high PUFA content. Contains significant gamma-linolenic precursor activity. Phytosterols present at approximately 4,000-6,000 mg/kg, primarily beta-sitosterol, campesterol, and brassicasterol, contributing to cholesterol-lowering effects. Phospholipid content: 0.5-1.5%. Carotenoids (lutein, beta-carotene) present in minor amounts at 1-5 mg/kg. Chlorophyll derivatives (1-10 mg/kg in unrefined oil) act as natural antioxidants. ALA bioavailability is moderate; conversion to EPA is estimated at 5-10% and to DHA at less than 1% in humans, consistent with other plant omega-3 sources. The oil is calorie-dense at approximately 884 kcal/100g (standard for refined vegetable oils). Contains no carbohydrates, fiber, or protein in the oil fraction. Polyphenolic compounds including sinapic acid derivatives contribute minor antioxidant activity.

Preparation & Dosage

Clinically studied doses range from 20g/day (liquid oil form) to 35g/day (via enriched crackers) for 12 weeks, typically combined with dietary interventions. No standardized extracts or powder forms have been studied. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Resistant dextrin (prebiotic), Vitamin E, Fish oil omega-3s, Milk thistle, Alpha-lipoic acid

Safety & Interactions

Camelina sativa oil is generally well-tolerated with minimal reported side effects in clinical trials. Mild gastrointestinal symptoms including nausea or loose stools may occur at doses above 15ml daily. The oil may enhance the effects of anticoagulant medications due to omega-3 content, requiring medical supervision for patients on warfarin or similar drugs. Safety during pregnancy and lactation has not been established in controlled studies.